Protracted treatment with MDMA induces heteromeric nicotinic receptor up-regulation in rat brain: an autoradiography study.

dc.contributor.authorCiudad Roberts, Andrés
dc.contributor.authorCamarasa García, Jordi
dc.contributor.authorEscubedo Rafa, Elena
dc.contributor.authorPubill Sánchez, David
dc.date.accessioned2014-04-03T17:53:53Z
dc.date.available2014-04-03T17:53:53Z
dc.date.issued2014-03-12
dc.date.updated2014-04-03T17:53:53Z
dc.description.abstractPrevious studies indicate that 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) can induce heteromeric nicotinic acetylcholine receptor (nAChR, mainly of α4β2 subtype) up-regulation. In this study we treated Sprague-Dawley rats twice-daily for 10 days with either saline or MDMA (7 mg/kg) and killed them on day 11 to perform [125I]epibatidine binding autoradiograms on serial coronal slices. Results showed significant increases in nAChR density in the substantia nigra, ventral tegmental area, nucleus accumbens, olfactory tubercle, anterior caudate-putamen, somatosensory cortex, motor cortex, auditory cortex, retrosplenial cortex, laterodorsal thalamus nuclei, amygdala, postsubiculum and pontine nuclei. These increases ranged from 3% (retrosplenial cortex) to 30 and 33% (amygdala and substantia nigra). No increased α4 subunit immunoreactivity was found in up-regulated areas compared with saline-treated rats, suggesting a post-translational mechanism as occurs with nicotine. The percentage of up-regulation correlated positively with the density of serotonin transporters, according to the serotonergic profile of MDMA. The heteromeric nAChR increase in concrete areas could account, at least in part, for the reinforcing, sensitizing and psychiatric disorders observed after long-term treatment with MDMA.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec634230
dc.identifier.issn0278-5846
dc.identifier.urihttps://hdl.handle.net/2445/53223
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.isformatofVersió postprint del document publicat a: http://dx.doi.org/10.1016/j.pnpbp.2014.02.014
dc.relation.ispartofProgress in Neuro-Psychopharmacology & Biological Psychiatry, 2014, vol. 53, p. 1-8
dc.relation.urihttp://dx.doi.org/10.1016/j.pnpbp.2014.02.014
dc.rights(c) Elsevier B.V., 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationCompostos heterocíclics
dc.subject.classificationÈxtasi (Droga)
dc.subject.classificationAmfetamines
dc.subject.classificationReceptors nicotínics
dc.subject.classificationRates (Animals de laboratori)
dc.subject.otherHeterocyclic compounds
dc.subject.otherEcstasy (Drug)
dc.subject.otherAmphetamines
dc.subject.otherNicotinic receptors
dc.subject.otherRats as laboratory animals
dc.titleProtracted treatment with MDMA induces heteromeric nicotinic receptor up-regulation in rat brain: an autoradiography study.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
634230.pdf
Mida:
799.97 KB
Format:
Adobe Portable Document Format